The goal of this clinical research study is to find the highest tolerable dose of 2 different
combinations of drugs that can be given to patients with advanced cancer. The first
combination of drugs is Tykerb (lapatinib) and Rapamune (sirolimus), and the second
combination is lapatinib and Glucophage (metformin). The safety of these drug combinations
will also be studied.